About us Mission and Vision Board of Directors Services Provided Alliance  

About us
Indicus Pharma is incorporated as a strategic alliance between USV Limited, India and Dr. Nitin Sheth (President & CEO: Indicus Pharma) with the goal of capitalizing on the opportunity in the US generic industry. This industry is growing due to various favorable factors such as increased awareness and acceptance of generics, as well as favorable legislation. Additionally, the large volume of branded products losing patent protection over the coming years and products which are already off-patent contribute to this growing opportunity.

The company intends to capitalize on this opportunity by leveraging its product development capabilities under the leadership of Dr. Nitin Sheth who has been associated with the US pharmaceutical industry for over 25 years. Dr. Sheth has obtained years of rich R&D experience, working with successful global pharmaceutical companies such as Eon Labs, Ivax and Cyanamid. Throughout his pharmaceutical career, Dr. Sheth has accumulated over 125 ANDA filings (including several P-IVs and of which many are first-to-file).

A new parenteral and ophthalmic product manufacturing facility was commissioned in 2009.

Our development product portfolio includes:
- Oral solid dosage forms
- Parenterals
- Ophthalmics

USV’s manufacturing facility is:
- inspected and approved by various international regulatory agencies, including the US FDA
- capable of handling commercial manufacturing of almost all solid oral products
- equipped with a state-of-the-art manufacturing infrastructure
- managed by an experienced and talented staff

USV has vast experience of the generic industry and is a reliable API Supplier with excellent regulatory support.

Current Status

Total ANDA submissions: 16
FDA Approvals: 5
       Home | About us | Mission | Directors | Services | Alliance | Contact us  

       © 2006 Indicus Pharma. All Rights Reserved.